CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Otsuka Pharmaceutical Co. Ltd. v. Hetero USA Inc.

1:14-cv-00421

Overview

Case Number 1:14-cv-00421
Filing Date 2014-04-04
Status Terminated
Termination Date 2015-12-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hetero Labs Ltd. Unit V Operating Company

Represented By

1 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Hetero Labs Ltd. Operating Company

Represented By

1 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Hetero USA Inc. Operating Company

Represented By

5 Attorneys Listed

Phoebe Fischer-Groban

Email: pfischergroban@choate.com

Margaret E. Ives

Email: mives@choate.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Frank D. Rodriguez

Email: frodriguez@windelsmarx.com

Anandita Vyakarnam

Email: avyakarnam@windelsmarx.com

Plaintiff

Otsuka Pharmaceutical Co. Ltd. Operating Company

Represented By

6 Attorneys Listed

Susan Krumplitsch

Email: susan.krumplitsch@us.dlapiper.com

Scott A. Sukenick

UNDELIVERABLE EMAIL 12/5/2017

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jonathan G. Graves

Email: jgraves@cooley.com

Adam M. Pivovar

Email: apivovar@cooley.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2015-01-29
1:15-cv-00109

Otsuka Pharmaceutical Co. Ltd. v. Apotex Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8501730
Process for preparing benzazepine compounds or salts thereof
Filed: 2012-05-17
Issued: 2013-08-06
Active (5.5 yrs remaining)
Expires: 2032-05-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

49

Dispositive

0

Granted

0

Denied

0

Pending / Review

23

Motions by Category

Claim Construction / Markman Filing 32 Procedural / Extension Motion 17

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 8/24/2015. (Court Reporter Valerie Gunning.) Associated Cases: 1:14-...
Entry #β€” • 2015-08-24
Claim Construction / Markman Filing Pending
Markman Hearing
Entry #β€” • 2015-08-24
Claim Construction / Markman Filing Pending / Under Review
Letter to The Honorable Richard G. Andrews from Robert K. Beste requesting to excuse Hetero USA Inc., Hetero Labs Ltd., Hetero Labs Ltd. Unit V from 8/24/15 cla...
Entry #69 • 2015-08-20 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (68 in 1:14-cv-00421-RGA, 60 in 1:15-cv-00109-RGA) STIPULATION To Extend Time for the parties to substantially complete document production to Se...
Entry #β€” • 2015-08-17
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to substantially complete document production to September 4, 2015 - filed by Otsuka Pharmaceutical Co. Ltd.. (Noreik...
Entry #68 • 2015-08-14 Document →
Claim Construction / Markman Filing Pending / Under Review
[SEALED] Joint Claim Construction Brief, filed by Otsuka Pharmaceutical Co. Ltd.. (Noreika, Maryellen) Modified on 8/7/2015 (nms). (Entered: 08/07/2015)
Entry #61 • 2015-08-07 Document →

Docket Entries

(149 total)
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1492275) filed by Otsuka Pharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mdb) (Entered: 04/07/2014)

Entry #1 • 2014-04-04
1
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1492275) filed by Otsuka Pharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mdb) (Entered: 04/07/2014)

Entry #1 • 2014-04-04
2
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1492275) filed by Otsuka Pharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mdb) (Entered: 04/07/2014)

Entry #1 • 2014-04-04
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mdb) (Entered: 04/07/2014)

Entry #2 • 2014-04-04
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/18/14. Date of Expiration of Patent: 9/1/26.Thirty Month Stay Deadline: 11/19/2016. (mdb) (Entered: 04/07/2014)

Entry #3 • 2014-04-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc